Lupin Q2 FY27 Results: Sales Rise 14% but Net Profit Falls 22% as Costs Climb
What the Lupin Q2 FY27 results show: sales up 14% to ₹7,786 crore, net profit down 22.2%, and how the US, India and other regions contributed.
What the Lupin Q2 FY27 results show: sales up 14% to ₹7,786 crore, net profit down 22.2%, and how the US, India and other regions contributed.
What the Emcure Pharma Q2 FY27 results show: revenue up 24.3%, international sales up 34.5% and a raised full-year revenue growth outlook above 20%.